KFH - SAN FRANCISCO
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.4M
- Transactions
- 432
- Companies
- 21
- Average per transaction
- $5,658
Who reported the payments
| Merck | $963,006 |
| Boston Scientific | $443,672 |
| Amgen | $409,408 |
| Incyte Corporation | $257,881 |
| Endotronix, Inc. | $149,951 |
| W. L. Gore & Associates, Inc. | $138,591 |
| Pi-cardia, Inc. | $42,564 |
| Mallinckrodt Hospital Products Inc. | $10,275 |
| Olympus America Inc. | $6,330 |
| E.r. Squibb & Sons, L.L.C. | $5,243 |
| Biogen | $5,050 |
| Masimo Corporation | $4,960 |
| Barco, Inc. | $2,347 |
| Stryker | $2,156 |
| Aesculap, Inc. | $1,301 |
| Medtronic | $641 |
| Macrogenics, Inc. | $441 |
| Samsung HME America, Inc. | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | $109 |
| Fisher & Paykel Healthcare Inc | $32 |
| Welch Allyn | $12 |